Induction of the presence of corpus luteum during superovulatory treatments enhances in vivo and in vitro blastocysts output in sheep.
This report offers the results of two experiments developed to test possible benefitial effects of the presence of corpus luteum (CL) on in vivo and in vitro sheep embryo production; using two different breeds treated with two different protocols by two different teams at two different centres. In the first trial, estrus was synchronized in 11 ewes with two doses of cloprostenol, 10 days apart. On day 1 after estimated ovulation, sheep were treated with progestagen sponges and superovulated with eight decreasing doses (26.4 units NIH-FSH-S1 x 3, 22.0 units x 2, and 17.6 units x 3) of ovine FSH injected twice daily. Ovulation rate and number of embryos obtained in vivo were compared to those from 12 control ewes without cloprostenol treatment. Presence of a CL improves the number of transferable embryos (7.4+/-0.6 versus 4.1+/-0.6 in control ewes, P < 0.05). The second trial investigated the effects of the presence of CL on embryos produced in vitro from six ewes bearing CL and six ewes without CL at start a superovulatory treatment consisting of 96 units of ovine FSH administered in four equal doses given every 12 h. There were not detected effects of the CL on the number and size of follicles or in the number, morphology and ability to resume meiosis of their oocytes. However, oocytes from ewes with CL showed higher rates of fertilization (73.5 versus 45.5%, P < 0.005), higher development to blastocyst (35.8 versus 19.3%, P < 0.01) and higher hatching rates after vitrification (80.0 versus 25.0%, P < 0.05).
Gonzalez-Bulnes
A
A
Departmento de Reproduccion Animal INIA, Avda. Puerta de Hierro s/n, 28040 Madrid, Spain. bulnes@inia.es
Berlinguer
F
F
Cocero
M J
MJ
Garcia-Garcia
R M
RM
Leoni
G
G
Naitana
S
S
Rosati
I
I
Succu
S
S
Veiga-Lopez
A
A
D000818:Animals; D001755:Blastocyst / Q000502:physiology*; D001947:Breeding; D003008:Cloprostenol / Q000494:pharmacology; D003338:Corpus Luteum / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004973:Estrus Synchronization / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology*; D011247:Pregnancy; D012756:Sheep / Q000502:physiology*; D013480:Superovulation / Q000187:drug effects
D003008:Cloprostenol; D005640:Follicle Stimulating Hormone